LifeMD, Inc. SEC filings LFMD

LifeMD, Inc. has 578 filings in SEC EDGAR's recent list, going back to May 17, 2012. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

LifeMD, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Sep 25, 2026 —
8-K Current report
Regulation FD disclosure
Sep 15, 2026 Sep 15, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 5, 2026 Aug 5, 2026
8-K Current report
Regulation FD disclosure
Jun 22, 2026 Jun 22, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 6, 2026 May 6, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Apr 30, 2026
S-8 Employee stock plan registration Apr 1, 2026 —
8-K Current report
Officer or director change, Other events
Mar 18, 2026 Mar 16, 2026
10-K Annual report Mar 10, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 9, 2026 Mar 9, 2026
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Jan 6, 2026 Jan 2, 2026
10-Q Quarterly report Nov 17, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 17, 2025 Nov 17, 2025
NT 10-Q Filing Nov 12, 2025 Sep 30, 2025
8-K Current report
Regulation FD disclosure
Nov 5, 2025 Nov 5, 2025
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Nov 4, 2025 Nov 4, 2025
8-K Current report
Auditor change
Aug 21, 2025 Aug 15, 2025
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Officer or director change, Other events
Jul 31, 2025 Jul 31, 2025
8-K Current report
Shareholder vote results
Jun 16, 2025 Jun 13, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
8-K Current report
Regulation FD disclosure
Apr 29, 2025 Apr 25, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Apr 28, 2025
8-K Current report
Auditor change
Apr 25, 2025 Apr 24, 2025
10-K Annual report Mar 11, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 10, 2025 Mar 10, 2025
UPLOAD Letter from the SEC Feb 14, 2025 —
CORRESP Letter to the SEC Jan 31, 2025 —
UPLOAD Letter from the SEC Jan 17, 2025 —
S-8 Employee stock plan registration Jan 13, 2025 —
8-K Current report
Officer or director change
Dec 31, 2024 Dec 24, 2024
8-K Current report
Officer or director change
Dec 23, 2024 Dec 18, 2024
CORRESP Letter to the SEC Dec 12, 2024 —
UPLOAD Letter from the SEC Nov 22, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Officer or director change
Oct 31, 2024 Oct 25, 2024
CORRESP Letter to the SEC Oct 25, 2024 —
UPLOAD Letter from the SEC Oct 16, 2024 —
424B3 Prospectus Aug 13, 2024 —
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
EFFECT Filing Jul 18, 2024 —
EFFECT Filing Jul 18, 2024 —
CORRESP Letter to the SEC Jul 16, 2024 —
CORRESP Letter to the SEC Jul 16, 2024 —
S-3/A Filing Jul 5, 2024 —
S-3/A Filing Jul 5, 2024 —
S-8 Employee stock plan registration Jul 5, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2024 Jun 14, 2024
UPLOAD Letter from the SEC Jun 17, 2024 —
UPLOAD Letter from the SEC Jun 10, 2024 —
S-3 Shelf registration Jun 7, 2024 —
S-3 Shelf registration May 31, 2024 —
DEFR14A Filing May 24, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Officer or director change, Other events
May 2, 2024 Apr 26, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Dec 31, 2023
S-8 Employee stock plan registration Mar 15, 2024 —
10-K Annual report Mar 11, 2024 Dec 31, 2023
S-8 Employee stock plan registration Dec 21, 2023 —
8-K Current report
Unregistered share sale, Regulation FD disclosure, Other events
Dec 13, 2023 Dec 11, 2023
8-K Current report
Officer or director change
Nov 14, 2023 Nov 8, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Regulation FD disclosure
Aug 10, 2023 Aug 9, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Officer or director change
Jul 31, 2023 Jul 28, 2023
8-K Current report
Officer or director change
Jul 14, 2023 Jul 11, 2023
8-K Current report
Shareholder vote results
Jul 7, 2023 Jun 16, 2023
424B5 Prospectus supplement Jun 29, 2023 —
8-K Current report
Officer or director change, Other events
Jun 22, 2023 Jun 20, 2023
8-K Current report
Officer or director change
Jun 20, 2023 Jun 15, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Apr 28, 2023
424B5 Prospectus supplement Mar 27, 2023 —
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Mar 23, 2023 Mar 21, 2023
10-K Annual report Mar 22, 2023 Dec 31, 2022
8-K Current report
Officer or director change, Other events
Feb 10, 2023 Feb 9, 2023
8-K Current report
Material agreement, Unregistered share sale
Feb 10, 2023 Feb 4, 2023
8-K Current report
Officer or director change
Dec 21, 2022 Dec 15, 2022
8-K Current report
Regulation FD disclosure
Nov 14, 2022 Nov 11, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Officer or director change, Other events
Sep 20, 2022 Sep 14, 2022
8-K Current report
Auditor change
Sep 14, 2022 Sep 8, 2022
424B3 Prospectus Aug 17, 2022 —
424B3 Prospectus Aug 17, 2022 —
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
EFFECT Filing Jul 7, 2022 —
POS AM Filing Jul 1, 2022 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 22, 2022 Jun 16, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
EFFECT Filing May 2, 2022 —
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Apr 29, 2022
POS AM Filing Mar 28, 2022 —
10-K Annual report Mar 7, 2022 Dec 31, 2021
8-K Current report
Material agreement, Acquisition or sale of assets
Feb 22, 2022 Jan 13, 2022
8-K Current report
Regulation FD disclosure
Feb 22, 2022 Feb 22, 2022
8-K Current report
Officer or director change
Feb 7, 2022 Feb 4, 2022
8-K Current report
Officer or director change
Feb 2, 2022 Jan 27, 2022
8-K Current report
Regulation FD disclosure
Jan 19, 2022 Jan 19, 2022
8-K Current report
Results of operations
Jan 19, 2022 Jan 19, 2022
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 12, 2022 Jan 11, 2022
8-K Current report
Officer or director change
Nov 12, 2021 Nov 8, 2021
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
CERT Filing Oct 4, 2021 —
8-A12B Filing Oct 4, 2021 —
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Oct 4, 2021 Sep 28, 2021
424B5 Prospectus supplement Oct 1, 2021 —
424B5 Prospectus supplement Sep 30, 2021 —
FWP Free writing prospectus Sep 30, 2021 —
424B5 Prospectus supplement Sep 28, 2021 —
424B5 Prospectus supplement Sep 28, 2021 —
8-K Current report
Regulation FD disclosure
Sep 27, 2021 Sep 27, 2021
8-K Current report
Regulation FD disclosure
Sep 22, 2021 Sep 22, 2021
8-K Current report
Officer or director change, Other events
Sep 13, 2021 Sep 8, 2021
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
8-K Current report
Officer or director change
Aug 4, 2021 Jul 30, 2021
EFFECT Filing Aug 2, 2021 —
CORRESP Letter to the SEC Jul 30, 2021 —
UPLOAD Letter from the SEC Jul 29, 2021 —
S-3 Shelf registration Jul 23, 2021 —
8-K Current report
Officer or director change
Jul 22, 2021 Jul 19, 2021
8-K Current report
Other events
Jul 15, 2021 Jul 15, 2021
8-K Current report
Officer or director change
Jul 2, 2021 Jun 29, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 29, 2021 Jun 24, 2021
EFFECT Filing Jun 22, 2021 —
S-3/A Filing Jun 22, 2021 —
8-K Current report
Officer or director change
Jun 21, 2021 Jun 15, 2021
CORRESP Letter to the SEC Jun 17, 2021 —
S-3/A Filing Jun 17, 2021 —
8-K Current report
Officer or director change, Other events
Jun 16, 2021 Jun 11, 2021
UPLOAD Letter from the SEC Jun 15, 2021 —
S-3 Shelf registration Jun 8, 2021 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jun 3, 2021 Jun 1, 2021
8-K Current report
Other events
Jun 1, 2021 May 28, 2021
EFFECT Filing May 24, 2021 —
S-1/A Amended registration statement May 21, 2021 —
CORRESP Letter to the SEC May 20, 2021 —
8-K Current report
Other events
May 19, 2021 Apr 18, 2021
DEFA14A Additional proxy material May 18, 2021 —
10-Q Quarterly report May 14, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 13, 2021 May 13, 2021
DEF 14A Proxy statement May 12, 2021 May 12, 2021
UPLOAD Letter from the SEC May 5, 2021 —
S-1 Registration statement Apr 28, 2021 —
PRE 14A Preliminary proxy statement Apr 28, 2021 Apr 28, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Apr 19, 2021 Apr 19, 2021
8-K Current report
Other events
Apr 16, 2021 Apr 16, 2021
8-K Current report
Other events
Apr 15, 2021 Apr 15, 2021
8-K Current report
Unregistered share sale, Officer or director change
Apr 6, 2021 Apr 2, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Apr 1, 2021 Mar 29, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020
8-K Current report
Unregistered share sale
Feb 26, 2021 Feb 24, 2021
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Feb 22, 2021 Feb 18, 2021
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 12, 2021 Feb 11, 2021
8-K Current report
Unregistered share sale, Officer or director change, Other events
Feb 10, 2021 Feb 4, 2021
8-K Current report
Unregistered share sale, Officer or director change
Feb 4, 2021 Feb 3, 2021
8-K Current report
Regulation FD disclosure
Feb 2, 2021 Feb 1, 2021
8-K/A Amended current report
Material agreement, New debt, Other events
Jan 28, 2021 Jan 22, 2021
8-K Current report
Material agreement, New debt
Jan 26, 2021 Jan 22, 2021
8-K Current report
Results of operations
Jan 19, 2021 Jan 19, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jan 14, 2021 Jan 8, 2021
8-K Current report
Unregistered share sale, Officer or director change, Other events
Jan 14, 2021 Jan 11, 2021
8-K Current report
Unregistered share sale, Officer or director change, Other events
Jan 11, 2021 Jan 5, 2021
EFFECT Filing Dec 31, 2020 —
CORRESP Letter to the SEC Dec 29, 2020 —
S-1/A Amended registration statement Dec 29, 2020 —
8-K Current report
Unregistered share sale, Officer or director change
Dec 28, 2020 Dec 21, 2020
8-K Current report
Unregistered share sale, Officer or director change
Dec 11, 2020 Dec 8, 2020
CERT Filing Dec 9, 2020 —
8-A12B Filing Dec 9, 2020 —
DEF 14A Proxy statement Dec 7, 2020 Dec 7, 2020
UPLOAD Letter from the SEC Dec 7, 2020 —
CORRESP Letter to the SEC Dec 3, 2020 —
PRER14A Filing Dec 3, 2020 —
8-K Current report
Unregistered share sale, Officer or director change
Dec 3, 2020 Nov 27, 2020
UPLOAD Letter from the SEC Dec 2, 2020 —
UPLOAD Letter from the SEC Nov 30, 2020 —
S-1 Registration statement Nov 25, 2020 —
8-K Current report
Unregistered share sale, Officer or director change, Other events
Nov 25, 2020 Nov 20, 2020
PRER14A Filing Nov 25, 2020 —
CORRESP Letter to the SEC Nov 24, 2020 —
D Filing Nov 20, 2020 —
8-K Current report
Material agreement, Unregistered share sale
Nov 20, 2020 Nov 19, 2020
8-K Current report
Other events
Nov 17, 2020 Nov 17, 2020
10-Q Quarterly report Nov 16, 2020 Sep 30, 2020
8-K Current report
Unregistered share sale, Officer or director change, Other events
Nov 10, 2020 Nov 6, 2020
8-K Current report
Material agreement, Unregistered share sale
Nov 4, 2020 Nov 3, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
LFMD (Nasdaq), LFMDP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Accelerated filer
SEC CIK
948320
Former names
CONVERSION LABS, INC. (until Feb 22, 2021); Immudyne, Inc. (until Jun 19, 2018)

Other Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.